{"brief_title": "Study of Aripiprazole in Patients With Acute Bipolar Mania", "brief_summary": "The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.", "condition": ["Bipolar Disorder"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["Placebo", "Aripiprazole", "Haloperidol"], "description": ["Tablets/capsules, oral, 0 mg, once daily, 3 weeks (switched to arm B for an additional 9 weeks).", "Tablets, oral, 15-30 mg, once daily, 12 weeks.", "Capsule, oral, 5-15 mg, once daily, 12 weeks."], "arm_group_label": ["A", "B", "C"], "other_name": ["Abilify"], "criteria": "Inclusion Criteria: - Subjects with Bipolar I Disorder and a diagnosis of acute mania will be considered for this study.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Bipolar Mania", "mesh_term": ["Bipolar Disorder", "Haloperidol", "Aripiprazole"], "id": "NCT00097266"}